MCC Offers In-Depth Study of Risk-Based Monitoring Practices Currently Utilized in the Industry

Jun 13, 2014
By Applied Clinical Trials Editors

MCC released an in-depth report on risk-based monitoring practices, “Taking the Risk-Based Monitoring Plunge: Who’s doing it, how they’re approaching it, and the metrics they’re using to manage it.” The new RBM Report provides current RBM users the ability to compare the RBM methods they currently employ to those utilized by a large sample of biopharmaceutical, CRO and academic research organizations. The report includes over 40 figures, tables and graphs covering a wide range of topics and is available for purchase through MCC.

Read the full release here.

lorem ipsum